These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27739631)

  • 1. Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.
    Mi P; Wang F; Nishiyama N; Cabral H
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27739631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics.
    Gan S; Lin Y; Feng Y; Shui L; Li H; Zhou G
    Int J Nanomedicine; 2018; 13():4263-4281. PubMed ID: 30087559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional hypoxia imaging nanoparticles: multifunctional tumor imaging and related guided tumor therapy.
    Liu J; Liu Z; Wu D
    Int J Nanomedicine; 2019; 14():707-719. PubMed ID: 30705587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors.
    Domingues C; Alvarez-Lorenzo C; Concheiro A; Veiga F; Figueiras A
    Mol Pharm; 2019 Dec; 16(12):4757-4774. PubMed ID: 31633939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Imaging and Gene Therapy with Neuroblastoma-Targeting Polymeric Nanoparticles for Potential Theranostic Applications.
    Lee J; Jeong EJ; Lee YK; Kim K; Kwon IC; Lee KY
    Small; 2016 Mar; 12(9):1201-11. PubMed ID: 26573885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Li R; Liu B; Gao J
    Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-Graphene Nanoassemblies and their Applications in Cancer Theranostics.
    Sivakumar PM; Islami M; Zarrabi A; Khosravi A; Peimanfard S
    Anticancer Agents Med Chem; 2020; 20(11):1340-1351. PubMed ID: 31746307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics.
    Ray S; Li Z; Hsu CH; Hwang LP; Lin YC; Chou PT; Lin YY
    Theranostics; 2018; 8(22):6322-6349. PubMed ID: 30613300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyrin-Based Nanomedicines for Cancer Treatment.
    Xue X; Lindstrom A; Li Y
    Bioconjug Chem; 2019 Jun; 30(6):1585-1603. PubMed ID: 31023011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 13. Near-infrared light-activatable polymeric nanoformulations for combined therapy and imaging of cancer.
    Yue X; Zhang Q; Dai Z
    Adv Drug Deliv Rev; 2017 Jun; 115():155-170. PubMed ID: 28455188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.
    Goos JACM; Cho A; Carter LM; Dilling TR; Davydova M; Mandleywala K; Puttick S; Gupta A; Price WS; Quinn JF; Whittaker MR; Lewis JS; Davis TP
    Theranostics; 2020; 10(2):567-584. PubMed ID: 31903138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymeric nanoparticles: the future of nanomedicine.
    Banik BL; Fattahi P; Brown JL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostics based on AIEgens.
    Wang D; Lee MMS; Xu W; Kwok RTK; Lam JWY; Tang BZ
    Theranostics; 2018; 8(18):4925-4956. PubMed ID: 30429878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.